21 CFR 529.443
§ 529.443 Ciclesonide.
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 529.443, § 529.443 Ciclesonide, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/87684
- Permanent ID
ys:prov:87684@1- SHA-256
d4a896f00bf5e0cfe466937813b8391a0a6e6a8cb3b188f6dc940123db7075c5
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
(a) Specifications. A non-pressurized metered dose inhaler and drug cartridge combination containing a solution of 30 milligrams/milliliter of the prodrug ciclesonide. Each actuation releases 343 micrograms (mcg) of ciclesonide.
(b) Sponsor. See No. 000010 in § 510.600(c) of this chapter.
(c) Conditions of use—(1) Amount. Administer an initial dose of 8 actuations (2,744 mcg ciclesonide) twice daily for 5 days, followed by 12 actuations (4,116 mcg ciclesonide) once daily for 5 days.
(2) Indications for use. For the management of clinical signs associated with severe equine asthma.
(3) Limitations. Do not use in horses intended for human consumption. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.